Inflamed Language: FDA Sends Harsh Warning Letter To Allergan For Acne Drug
This article was originally published in The Pink Sheet Daily
Executive Summary
Allergan gets slammed for Aczone Gel promotional claims that FDA says are backed by data "not even nominally statistically significant."